|
Member
|
|
Join Date: Oct 2006
Location: New England
Posts: 262
|
|
|
Member
Join Date: Oct 2006
Location: New England
Posts: 262
|
Nilotinib, protects dopaminergic neurons
There have been posts here on Nilotnlib earlier. This is an FDA approved drug for cancer and it has been shown to work, at lower doses, for PD to clear out c-Abl activity. Does Michael Fox know about this?
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
http://www.nature.com/articles/srep04874#f7
https://gumc.georgetown.edu/news/Can...Clinical-Trial
http://www.georgetown.edu/news/cance...ons-study.html
http://lctglobal.com/upload/news/201...ns%20trial.pdf
|